GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Ending Cash Position

Pharmaresearch Bio Co (XKRX:217950) Ending Cash Position : ₩10,148 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Ending Cash Position?

Pharmaresearch Bio Co's Ending Cash Position for the quarter that ended in Dec. 2023 was ₩10,148 Mil.

Pharmaresearch Bio Co's quarterly Ending Cash Position increased from Dec. 2021 (₩8,892 Mil) to Dec. 2022 (₩9,219 Mil) and increased from Dec. 2022 (₩9,219 Mil) to Dec. 2023 (₩10,148 Mil).

Pharmaresearch Bio Co's annual Ending Cash Position increased from Dec. 2021 (₩8,892 Mil) to Dec. 2022 (₩9,219 Mil) and increased from Dec. 2022 (₩9,219 Mil) to Dec. 2023 (₩10,148 Mil).

Pharmaresearch Bio Co Ending Cash Position Historical Data

The historical data trend for Pharmaresearch Bio Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Ending Cash Position Chart

Pharmaresearch Bio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial 1,522.62 976.09 8,891.58 9,218.66 10,147.79

Pharmaresearch Bio Co Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position Get a 7-Day Free Trial 1,522.62 976.09 8,891.58 9,218.66 10,147.79

Pharmaresearch Bio Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Pharmaresearch Bio Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=9218.662+929.123
=10,148

Pharmaresearch Bio Co's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=9218.662+929.123
=10,148

Pharmaresearch Bio Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaresearch Bio Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Ending Cash Position
Comparable Companies
XKRX:388870 XKRX:084990 XKRX:166480 XKRX:338840 XKRX:378800 XKRX:235980 XKRX:217730 XKRX:365270 XKRX:251120 XKRX:348150 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494
Website
http://www.pr-bio.co.kr
Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co Headlines

No Headlines